Invitae Common Hereditary Cancers Panel
DEN210011 is the FDA 510(k) clearance record for Invitae Common Hereditary Cancers Panel, a class II device, cleared for Invitae Corporation on under FDA product code QVU (High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System.). FDA's definition for product code QVU reads: "A high throughput DNA sequencing for hereditary cancer predisposition assessment test system is a qualitative in vitro diagnostic (IVD) system intended for analysis of human DNA extracted from human specimens to detect germline mutations...". FDA records list one 510(k) clearance for Invitae Corporation. As of , FDA records show no recalls naming DEN210011.
Clearance record
- Decision date
- Received
- (914 days to decision)
- Product code
- QVU High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System.
- Regulation
- 21 CFR 866.6095
- Device class
- Class II
- Review panel
- Pathology
- Applicant
- Invitae Corporation 1400 16th St., San Francisco CA
- Third party review
- No
Clearances, product code QVU
Trailing 12 monthsFDA records hold no clearances under product code QVU in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
